Myocarditis associated with immune checkpoint inhibitors: Practical considerations in diagnosis and management
Immune checkpoint inhibitors (ICI) have caused radical changes in the treatment scheme of many types of cancer in the past 10 years. ICIs are specific monoclonal antibodies that increase T-cell mediated immune response against cancer cells. Despite important advances in cancer treatment, uncontrolle...
Main Authors: | Muhammet Gürdoğan, Kenan Yalta |
---|---|
Format: | Article |
Language: | English |
Published: |
KARE Publishing
2020-07-01
|
Series: | Anatolian Journal of Cardiology |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-79584 |
Similar Items
-
Research Progress of Immune Checkpoint Inhibitor-associated Myocarditis
by: Yunwei LIU, et al.
Published: (2021-09-01) -
Immune checkpoint inhibitor myocarditis: a systematic case study
by: E. A. Kushnareva, et al.
Published: (2020-12-01) -
Clinical manifestation and management of immune checkpoint inhibitor‐associated cardiotoxicity
by: Xiaoxiao Guo, et al.
Published: (2020-02-01) -
Role of Cardiac Imaging in the Diagnosis of Immune Checkpoints Inhibitors Related Myocarditis
by: Stéphane Ederhy, et al.
Published: (2021-05-01) -
Cardiovascular complications of immune checkpoint inhibitors
by: A. A. Kulievа, et al.
Published: (2020-04-01)